Alexandra Rizos

3.9k total citations
74 papers, 2.0k citations indexed

About

Alexandra Rizos is a scholar working on Neurology, Epidemiology and Neurology. According to data from OpenAlex, Alexandra Rizos has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Neurology, 14 papers in Epidemiology and 14 papers in Neurology. Recurrent topics in Alexandra Rizos's work include Parkinson's Disease Mechanisms and Treatments (70 papers), Neurological disorders and treatments (49 papers) and Botulinum Toxin and Related Neurological Disorders (16 papers). Alexandra Rizos is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (70 papers), Neurological disorders and treatments (49 papers) and Botulinum Toxin and Related Neurological Disorders (16 papers). Alexandra Rizos collaborates with scholars based in United Kingdom, Spain and Germany. Alexandra Rizos's co-authors include К. Ray Chaudhuri, Pablo Martínez‐Martín, Angelo Antonini, Monty Silverdale, Anna Sauerbier, Per Odin, Carmen Rodríguez‐Blázquez, Daniel Weintraub, Kapil D. Sethi and Anette Schrag and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Alexandra Rizos

72 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Rizos United Kingdom 29 1.8k 314 269 238 225 74 2.0k
Anna Sauerbier United Kingdom 23 1.4k 0.8× 290 0.9× 253 0.9× 228 1.0× 143 0.6× 56 1.6k
Mónica Kurtis Spain 18 1.7k 1.0× 360 1.1× 254 0.9× 344 1.4× 161 0.7× 36 2.0k
Beatriz Tijero Spain 21 1.1k 0.6× 212 0.7× 197 0.7× 220 0.9× 140 0.6× 62 1.4k
Mario Giorgio Rizzone Italy 30 2.2k 1.2× 161 0.5× 666 2.5× 363 1.5× 419 1.9× 75 2.5k
Rosa De Micco Italy 24 1.3k 0.8× 164 0.5× 262 1.0× 750 3.2× 210 0.9× 67 2.0k
Paulo Bugalho Portugal 24 720 0.4× 216 0.7× 319 1.2× 313 1.3× 107 0.5× 63 1.3k
Heike Stockner Austria 23 1.4k 0.8× 453 1.4× 284 1.1× 452 1.9× 129 0.6× 33 1.7k
María José Catalán Spain 13 853 0.5× 146 0.5× 198 0.7× 227 1.0× 253 1.1× 21 1.1k
Sophie Molloy United Kingdom 11 1.1k 0.6× 128 0.4× 445 1.7× 204 0.9× 109 0.5× 19 1.4k
Christopher W. Hess United States 26 1.2k 0.7× 77 0.2× 602 2.2× 282 1.2× 164 0.7× 72 1.7k

Countries citing papers authored by Alexandra Rizos

Since Specialization
Citations

This map shows the geographic impact of Alexandra Rizos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Rizos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Rizos more than expected).

Fields of papers citing papers by Alexandra Rizos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Rizos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Rizos. The network helps show where Alexandra Rizos may publish in the future.

Co-authorship network of co-authors of Alexandra Rizos

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Rizos. A scholar is included among the top collaborators of Alexandra Rizos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Rizos. Alexandra Rizos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaudhuri, К. Ray, Alexandra Rizos, Carmen Rodríguez‐Blázquez, et al.. (2025). Conversion between NMSS and MDS‐NMS in Parkinson's Disease. Movement Disorders. 40(5). 813–820. 1 indexed citations
2.
Sauerbier, Anna, Leire Ambrosio, Philipp Alexander Loehrer, et al.. (2024). Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson’s Disease. Journal of Personalized Medicine. 14(10). 1023–1023. 1 indexed citations
3.
Loehrer, Philipp Alexander, Stefanie T. Jost, Monty Silverdale, et al.. (2024). No evidence for an association of voxel-based morphometry with short-term non-motor outcomes in deep brain stimulation for Parkinson’s disease. npj Parkinson s Disease. 10(1). 91–91. 1 indexed citations
4.
Löhle, Matthias, Wolfgang H. Jost, Florin Gandor, et al.. (2024). Intercultural Translation and Application of the German Version of King’s Parkinson’s Disease Pain Questionnaire in Fluctuating Parkinson’s Disease. Acta Neurologica Scandinavica. 2024(1). 3 indexed citations
5.
Fujioka, Shinsuke, Yasuaki Mizutani, Hirohisa Watanabe, et al.. (2024). Validation study of the Japanese version of the King's Parkinson's Disease Pain Scale and the King's Parkinson's Disease Pain Questionnaire. Parkinsonism & Related Disorders. 120. 106012–106012. 4 indexed citations
6.
Rukavina, Katarina, Nicola Mulholland, Benjamin Corcoran, et al.. (2023). Musculoskeletal pain in Parkinson's disease: Association with dopaminergic deficiency in the caudate nucleus. European Journal of Pain. 28(2). 244–251. 8 indexed citations
7.
Jost, Stefanie T., Monty Silverdale, Alexandra Rizos, et al.. (2023). Stratifying quality of life outcome in subthalamic stimulation for Parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry. 95(7). 630–638. 6 indexed citations
8.
Leta, Valentina, Daniel J. van Wamelen, Vinod Metta, et al.. (2023). The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone. Journal of Neural Transmission. 130(7). 925–930. 4 indexed citations
9.
Batzu, Lucia, Silvia Rota, Abdul Hye, et al.. (2022). Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease. npj Parkinson s Disease. 8(1). 154–154. 40 indexed citations
10.
Rodríguez‐Blázquez, Carmen, Concha Bielza, Pedro Larrañaga, et al.. (2021). Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering. Scientific Reports. 11(1). 23645–23645. 19 indexed citations
11.
Dafsari, Haidar S., Maria Gabriela dos Santos Ghilardi, Veerle Visser‐Vandewalle, et al.. (2020). Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson’s disease. Brain stimulation. 13(6). 1697–1705. 41 indexed citations
12.
Dafsari, Haidar S., К. Ray Chaudhuri, Keyoumars Ashkan, et al.. (2020). Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson’s disease. Journal of Neurology. 267(6). 1830–1841. 19 indexed citations
13.
Dafsari, Haidar S., Monty Silverdale, Alexandra Rizos, et al.. (2018). Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease. Movement Disorders. 33(3). 421–430. 69 indexed citations
14.
Dafsari, Haidar S., Jan Niklas Petry‐Schmelzer, К. Ray Chaudhuri, et al.. (2018). Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts. Brain stimulation. 11(4). 904–912. 51 indexed citations
15.
Dafsari, Haidar S., Luisa Weiß, Monty Silverdale, et al.. (2018). Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease. Brain stimulation. 11(4). 867–874. 31 indexed citations
16.
Dafsari, Haidar S., Paul Reker, Monty Silverdale, et al.. (2017). Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age. Movement Disorders. 33(1). 99–107. 33 indexed citations
17.
Voon, Valerie, Alexandra Rizos, Nicola Mulholland, et al.. (2013). Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels. Journal of Neurology Neurosurgery & Psychiatry. 85(2). 148–152. 75 indexed citations
18.
Reddy, Prashanth, Pablo Martínez‐Martín, Alexandra Rizos, et al.. (2012). Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease. Clinical Neuropharmacology. 35(5). 205–207. 44 indexed citations
19.
Rizos, Alexandra, Y. Naidu, Anthony H.V. Schapira, et al.. (2011). Pain in Parkinson's disease: Observational study of 225 patients. UCL Discovery (University College London). 2 indexed citations
20.
Riegel, Bárbara, et al.. (2002). Implementation of a multidisciplinary disease management program for heart failure patients.. PubMed. 5(4). 164–170. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Sauerbier Breakdown of academic impact, for papers by Mónica Kurtis Breakdown of academic impact, for papers by Beatriz Tijero Breakdown of academic impact, for papers by Mario Giorgio Rizzone Breakdown of academic impact, for papers by Rosa De Micco Breakdown of academic impact, for papers by Paulo Bugalho Breakdown of academic impact, for papers by Heike Stockner Breakdown of academic impact, for papers by María José Catalán Breakdown of academic impact, for papers by Sophie Molloy Breakdown of academic impact, for papers by Christopher W. Hess
Rankless by CCL
2026